Lykos Therapeutics Announces Reorganization to Address FDA’s Recent Decision on Midomafetamine Capsules for PTSD

– Pharmaceutical industry veteran and former Janssen executive Dr. David Hough appointed senior medical advisor to oversee clinical and regulatory – Lykos to significantly reduce workforce, streamlining organization around clinical development and regulatory engagement – MAPS founder Dr….